The estimated Net Worth of Jason Grenfell Gardner is at least $68 Milion dollars as of 23 May 2019. Jason Gardner owns over 25,000 units of Pfenex stock worth over $67,810,564 and over the last 9 years Jason sold PFNX stock worth over $211,200.
Jason has made over 4 trades of the Pfenex stock since 2016, according to the Form 4 filled with the SEC. Most recently Jason bought 25,000 units of PFNX stock worth $17,250 on 23 May 2019.
The largest trade Jason's ever made was selling 52,800 units of Pfenex stock on 4 September 2018 worth over $211,200. On average, Jason trades about 7,021 units every 83 days since 2016. As of 23 May 2019 Jason still owns at least 119,849 units of Pfenex stock.
You can see the complete history of Jason Gardner stock trades at the bottom of the page.
Jason's mailing address filed with the SEC is C/O PFENEX INC., 10790 ROSELLE STREET, , SAN DIEGO, CA, 92121.
Over the last 10 years, insiders at Pfenex have traded over $99,496,796 worth of Pfenex stock and bought 36,000 units worth $174,640 . The most active insiders traders include Chemical Co /De/ Dow, James C Gale a Healthcare Partners Accredi.... On average, Pfenex executives and independent directors trade stock every 46 days with the average trade being worth of $90,240,574. The most recent stock trade was executed by Asset Management Lpweiss An... on 29 September 2020, trading 100,000 units of PFNX stock currently worth $1,274,000.
Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.
Pfenex executives and other stock owners filed with the SEC include: